The global Laparoscopic Gynecological Procedures market gathered revenue around USD 20.97 Billion in 2020 and market is set to grow USD 36.9 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 5.45% during the prediction period 2021 to 2027.
Growth Factors:
Increasing adoption of minimally invasive surgeries, rising prevalence of gynecological disorders, technological advances, favorable reimbursement policies, and various government initiatives are key factors contributing to the growth of the market. Technological advancements in laparoscopy devices are one of the major drivers of this market. Numerous market players are investing in R&D for developing innovative products. Technological advancements in laparoscopes, visualization systems, and other components are collectively boosting the product demand.
These advancements include HD imaging, portability, and micro laparoscopy, which enable accurate diagnoses & treatment. For instance, the development and introduction of medical robots to assist doctors is a key advancement in the field. These robots offer numerous benefits, such as a 3D view of the operating field, reduced blood loss & need for transfusion, early discharge from the hospital, minimal scarring & less trauma to the body, as well as higher precision in surgery due to the elimination of surgeon’s tremor. The usage of hand-assisted devices and robotic laparoscopic surgeries is among the new trends, boosting the market growth.
Some companies are focusing on innovations in hand access instruments, slide-lock graspers & trocars, and closure devices used in these surgeries. For instance, 5.0 mm sliding lock graspers by Stryker Corp. offer a variety of handle and insert styles for grasping, dissecting, suturing, and cutting capabilities. The sliding lock graspers offered by Aesculap provide excellent tissue and grip control. In addition, Nu-Tip Instruments manufactured by CooperSurgical Inc. feature a reusable handle with disposable stainless-steel tips and allow creating scissors, grasper, or dissector, based on need. Thus, technological advancements in designs will drive the growth potential of the market.
Furthermore, single-site incisional surgery is being widely used in laparoscopic procedures and is replacing traditional procedures, in which four to five small incisions were made as the entry point for laparoscopic instruments. Some of the key benefits of a single-site incision laparoscopic procedure are low chances of infections, better cosmetic results, quick recovery, and less post-operative pain. As per the Journal of the Society of Laparoendoscopic Surgeons (JSLS), women who underwent single-site incision laparoscopic surgery tend to report less postoperative pain compared to the ones who underwent the traditional procedure. Thus, the growing demand for single-incision laparoscopic surgery would boost the market growth over the forecast period.
This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Laparoscopic Gynecological Procedures market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Laparoscopic Gynecological Procedures market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.
Report Coverage
Report Scope | Details |
Market Size | USD 36.9 Billion by 2027 |
Growth Rate | CAGR of 5.45% From 2021 to 2027 |
Base Year | 2020 |
Forecast Period | 2021 to 2027 |
Historic Data | 2017 to 2020 |
Report coverage | Growth Factors, Revenue Status, Competitive Landscape, and Future Trends |
Segments Covered | Procedure, end use And Region |
Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA) |
Companies Mentioned | Medtronic; Stryker Corp.; Karl Storz SE & CO. Kg; Johnson and Johnson; Olympus Corp.; CONMED Corp.; B. Braun Melsungen AG; The Cooper Companies, Inc.; Richard Wolf GmbH; Microline Surgical; Welfare Medical Ltd.; Intuitive Surgical; Shenzen Mindray Bio Medical Electronics Co., Ltd.. |
COVID-19 Impact Assessment on Market Landscape
The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.
Laparoscopic Gynecological Procedures market Report empowers readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.
Regional analysis:
North America dominated the global market accounting for the share revenue share of 41.10% in 2020 owing to the presence of well-established healthcare infrastructure, availability of skilled surgeons, and launch of technologically advanced products by the key market players. Growing awareness about the benefits of minimally invasive surgeries and laparoscopic procedures will drive the market growth over the forecast years. In addition, increasing healthcare expenditure in the U.S. may also favor the entry of both new and old players.
For instance, as per the Centers for Medicare and Medicaid Services, the U.S. healthcare spending increased by 4.0% and reached USD 3.8 trillion in 2019, accounting for approximately 17.7% of the GDP. The National Health spending is expected to grow at an annual rate of 6.2% from 2019 to 2027, to reach USD 6.0 trillion by 2027. Furthermore, several government and non-government bodies increased their funding in healthcare sectors to support innovations and technological advancements in surgeries & other fields.
For instance, healthcare finance by local and state governments had increased to 4.1% in 2017 from 3.8% in 2016. These factors indicate that the U.S. market would exhibit considerable growth over the forecast period. The market in Asia Pacific is majorly driven by China, Japan, India, Singapore, and Australia. China dominated the APAC regional market, in terms of revenue share, in 2020. The market in China is driven by a rise in disposable income levels and a fast-growing geriatric population.
According to the China Population and Development Research Center, approximately 350.0 million people in China will be above the age of 65 years by 2050. In addition, as per the WHO, by 2020, China will have 400 million people aged 60 years & above and about 100 million people aged 80 years. Other driving factors include affordable devices, an increase in mergers & acquisitions, and government initiatives to improve healthcare services. The government in the country has made significant investments to provide basic health insurance to all its citizens.
Competitive Rivalry
Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
Some of the prominent players in the Laparoscopic Gynecological Procedures Market include: Medtronic; Stryker Corp.; Karl Storz SE & CO. Kg; Johnson and Johnson; Olympus Corp.; CONMED Corp.; B. Braun Melsungen AG; The Cooper Companies, Inc.; Richard Wolf GmbH; Microline Surgical; Welfare Medical Ltd.; Intuitive Surgical; Shenzen Mindray Bio Medical Electronics Co., Ltd.
Unravelling the Critical Segments
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Highlights of the Report:
Research Methodology
In the study, a unique research methodology is utilized to conduct extensive research on the growth of the Laparoscopic Gynecological Procedures market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of the Laparoscopic Gynecological Procedures market study are as follows - statistics from government organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, all of whom have contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the market, and makes the projections on the growth prospects of the Laparoscopic Gynecological Procedures markets more accurate and reliable.
Secondary Research
It involves company databases such as Hoover's: This assists us recognize financial information, structure of the market participants and industry competitive landscape.
The secondary research sources referred in the process are as follows:
Primary Research
Primary research includes face-to face interviews, online surveys, and telephonic interviews.
Industry participants involved in this research study include:
Key Points Covered in Laparoscopic Gynecological Procedures market Study:
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Laparoscopic Gynecological Procedures Market, By Procedure
7.1. Laparoscopic Gynecological Procedures Market, By Procedure, 2021-2027
7.1.1. Laparoscopic Hysterectomy
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Laparoscopic Myomectomy
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. Laparoscopic Colpopexy (Sacrocolpopexy, Sacrocervicopexy, etc.)
7.1.3.1. Market Revenue and Forecast (2016-2027)
7.1.4. Laparoscopic Endometrial Excision
7.1.4.1. Market Revenue and Forecast (2016-2027)
7.1.5. Laparoscopic Adnexal (Oophorectomy, SalpingoOophorectomy, etc.)
7.1.5.1. Market Revenue and Forecast (2016-2027)
7.1.6. Laparoscopic Diagnostic Procedures (Requiring Chromopertubation)
7.1.6.1. Market Revenue and Forecast (2016-2027)
Chapter 8. Global Laparoscopic Gynecological Procedures Market, By End-use
8.1. Laparoscopic Gynecological Procedures Market, By End-use, 2021-2027
8.1.1. Hospitals
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Clinics
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Ambulatory Surgery Centers (ASCs)
8.1.3.1. Market Revenue and Forecast (2016-2027)
Chapter 9. Global Laparoscopic Gynecological Procedures Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, By Procedure (2016-2027)
9.1.2. Market Revenue and Forecast, By End-use (2016-2027)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, By Procedure (2016-2027)
9.1.3.2. Market Revenue and Forecast, By End-use (2016-2027)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, By Procedure (2016-2027)
9.1.4.2. Market Revenue and Forecast, By End-use (2016-2027)
9.2. Europe
9.2.1. Market Revenue and Forecast, By Procedure (2016-2027)
9.2.2. Market Revenue and Forecast, By End-use (2016-2027)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, By Procedure (2016-2027)
9.2.3.2. Market Revenue and Forecast, By End-use (2016-2027)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, By Procedure (2016-2027)
9.2.4.2. Market Revenue and Forecast, By End-use (2016-2027)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, By Procedure (2016-2027)
9.2.5.2. Market Revenue and Forecast, By End-use (2016-2027)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, By Procedure (2016-2027)
9.2.6.2. Market Revenue and Forecast, By End-use (2016-2027)
9.3. APAC
9.3.1. Market Revenue and Forecast, By Procedure (2016-2027)
9.3.2. Market Revenue and Forecast, By End-use (2016-2027)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, By Procedure (2016-2027)
9.3.3.2. Market Revenue and Forecast, By End-use (2016-2027)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, By Procedure (2016-2027)
9.3.4.2. Market Revenue and Forecast, By End-use (2016-2027)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, By Procedure (2016-2027)
9.3.5.2. Market Revenue and Forecast, By End-use (2016-2027)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, By Procedure (2016-2027)
9.3.6.2. Market Revenue and Forecast, By End-use (2016-2027)
9.4. MEA
9.4.1. Market Revenue and Forecast, By Procedure (2016-2027)
9.4.2. Market Revenue and Forecast, By End-use (2016-2027)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, By Procedure (2016-2027)
9.4.3.2. Market Revenue and Forecast, By End-use (2016-2027)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, By Procedure (2016-2027)
9.4.4.2. Market Revenue and Forecast, By End-use (2016-2027)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, By Procedure (2016-2027)
9.4.5.2. Market Revenue and Forecast, By End-use (2016-2027)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, By Procedure (2016-2027)
9.4.6.2. Market Revenue and Forecast, By End-use (2016-2027)
9.5. Latin America
9.5.1. Market Revenue and Forecast, By Procedure (2016-2027)
9.5.2. Market Revenue and Forecast, By End-use (2016-2027)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, By Procedure (2016-2027)
9.5.3.2. Market Revenue and Forecast, By End-use (2016-2027)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, By Procedure (2016-2027)
9.5.4.2. Market Revenue and Forecast, By End-use (2016-2027)
Chapter 10. Company Profiles
10.1. Medtronic
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Stryker Corp
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Karl Storz SE & CO. Kg
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Johnson and Johnson
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Olympus Corp
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. CONMED Corp.
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. B. Braun Melsungen AG
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. The Cooper Companies, Inc
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Richard Wolf GmbH
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. Microline Surgical
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
Chapter 11. Research Methodology
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
Chapter 12. Appendix
12.1. About Us
12.2. Glossary of Terms